Upcoming EL-PFDD Meetings

To promote transparency and communication, FDA is sharing a list of disease areas where a letter of intent (LOI) has been submitted and ongoing plans exist for a future Externally-Led PFDD meeting. While multiple organizations may be working together, the organizations listed below are the primary points of contact for any questions regarding their EL-PFDD meeting. FDA does not conduct Externally-Led PFDD meetings and a listing on this webpage does not reflect endorsement. Questions? To contact FDA’s CDER Patient-Focused Drug Development Program Staff, please email patientfocused@fda.hhs.gov. To get updates about CDER’s Patient-Focused Drug Development programs, subscribe to our free email subscription service at the bottom of the page.